Indication
Advanced Malignant Tumors Lymphomas
1 clinical trial
1 product
Product
IBI322Clinical trial
A Phase 1a Study Evaluating the Safety, Tolerability and Preliminary Efficacy of IBI322 in Subjects With Advanced Malignant TumorsStatus: Completed, Estimated PCD: 2023-02-28